Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Drugging resistant androgen receptors

Oct. 29, 2020

Novel selective TRK degraders effectively reduce TPM3-TRKA fusion protein levels

Oct. 28, 2020

Apollomics reports phase I data for APL-101

Oct. 28, 2020

First-in-human data presented for TPX-0022

Oct. 28, 2020

SIMR-1281: a novel candidate for clinical trials in cancer

Oct. 28, 2020

XL-092: a promising pan-tyrosine kinase inhibitor in clinical development

Oct. 28, 2020

Shanghai Hansoh Biomedical, Jiangsu Hansoh Pharmaceutical patent ERK-1/2 inhibitors

Oct. 28, 2020

University of Florida identifies new PRMT5 inhibitors

Oct. 28, 2020

Preclinical and clinical data presented for taminadenant + spartalizumab in cancer

Oct. 27, 2020

Ascentage cleared to begin phase Ib/II study of APG-115 for liposarcoma in China

Oct. 27, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...